Enhancing Formulation Success with UltraBurst™ Platform for Orally Disintegrating Tablets
Are you a pharmaceutical formulator looking for ways to improve your development process and create safe, effective, and patient-friendly dosage forms? If so, you might be interested in SPI Pharma's new platform for orally disintegrating tablets (ODTs), UltraBurst™.
UltraBurst™ is designed to maximise formulation success, whilst maintaining excellence in the final dosage form. With an easy-to-formulate platform and ultra-fast disintegration times, UltraBurst™ can help formulators overcome obstacles in their development process and create high-quality ODTs that patients will love.
To help you get started, SPI Pharma has released a new eBook that provides an abundance of information on how to use UltraBurst™ to develop direct compression platforms. This eBook is packed with insider secrets and tips that will help you make informed decisions and avoid common pitfalls in the formulation process.
One of the key benefits of UltraBurst™ is its easy-to-formulate platform. This makes it an ideal choice for formulators who want to streamline their development process and create ODTs quickly and efficiently. Additionally, UltraBurst™ offers ultra-fast disintegration times, which means that patients can take their medication without water, making it an excellent choice for those who have difficulty swallowing pills.
Another benefit of UltraBurst™ is its low friability, which means that it can withstand handling and packaging without breaking apart. This is important because it ensures that the tablet remains intact until it reaches the patient, ensuring the correct dose is delivered.
Finally, UltraBurst™ offers excellent organoleptics, which means that it is tasteless, odorless, and has a smooth mouthfeel. This makes it an ideal choice for patients who are sensitive to strong flavors or textures.
In summary, if you're looking for a platform to help you create safe, effective, and patient-friendly dosage forms, UltraBurst™ might be the key. With its easy-to-formulate platform, ultra-fast disintegration times, low friability, and excellent organoleptics, UltraBurst™ can help you overcome obstacles in your development process and create high-quality ODTs that patients will love. Check out SPI Pharma's new eBook to learn more about how to use UltraBurst™ to create direct compression platforms.